CISAPRIDE ACCELERATES COLONIC TRANSIT IN CONSTIPATED PATIENTS WITH COLONIC INERTIA

Authors:
  • AMAH MAURER
    AH MAURER
  • LMLS MALMUD
    LS MALMUD
  • RFRS FISHER
    RS FISHER

  • 1 August 1989
    • journal article
    • research article
    • Vol. 84  (8) , 882-887
    • PMID:2667336
Abstract
A double-blind cross-over trial of oral cisapride 10 mg before meals and placebo was performed to determine its effects on colonic transit in patients with severe idiopathic constipation. Nine patients with < 3 spontaneous bowel movements/wk were studied. After passing a tube to the cecum, 50 .mu.Ci of 111In-DTPA were instilled into the cecum and followed for 48 h using colonic transit scintigraphy. In the group as a whole, cisapride had little effect on transit. The patients were then divided into two groups based on transit: functional rectosigmoid obstruction (FRSO) and colonic inertia (CI). In the CI group, cisapride accelerated the half emptying time of the cecum and ascending colon from 2.50 to 1.21 h (p < 0.05). The progression of the geometric center was also faster after cisapride in CI. In FRSO, the geometric center was unchanged by cisapride except at 48 h. Cisapride thus has a prokinetic effect on colonic transit in patients with severe idiopathic constipation, colonic inertia subtype. It may be a useful agent in the treatment of this group of patients.

This publication has 13 references indexed in Scilit: